• SIRT6 Loss Drives Proteostasis Breakdown via Nucleolar Remod

  2026-05-26

  This study establishes SIRT6 as a key regulator of proteostasis, demonstrating that its loss leads to nucleolar expansion, increased protein synthesis, and impaired protein folding, ultimately accelerating neurodegeneration. The findings reframe the role of chromatin regulation in aging and highlight nucleolar dysfunction as an early, targetable driver of proteostasis failure.

• Triiodothyronine (T3) for Advanced Adipocyte and Metabolism

  2026-05-26

  Triiodothyronine (T3) unlocks precision in adipocyte differentiation and metabolic regulation assays by directly modulating thyroid hormone receptor pathways. This article distills recent mechanistic findings and workflow enhancements, empowering researchers to optimize cellular metabolism studies and troubleshoot common pitfalls with confidence.

• HyperTrap Heparin HP Column: Enabling Stem Cell Pathway Disc

  2026-05-25

  Explore how the HyperTrap Heparin HP Column empowers high-resolution purification in cancer stem cell signaling studies. This in-depth guide highlights unique workflow advantages and scientific insights for advanced research.

• (S)-(+)-Dimethindene maleate: Protocols for M2 Antagonism Re

  2026-05-25

  (S)-(+)-Dimethindene maleate is a selective M2 muscarinic and H1 histamine receptor antagonist, providing precise pharmacological control in autonomic regulation, cardiovascular physiology, and respiratory system research. It should be reserved for controlled in vitro and ex vivo assays, and is not intended for diagnostic or therapeutic use.

• Formononetin Prevents Oxaliplatin Neuropathy via Nrf2/HO-1 W

  2026-05-24

  The reference study identifies formononetin as a neuroprotectant that prevents oxaliplatin-induced peripheral neurotoxicity in DRG neurons by activating the Nrf2/HO-1 antioxidant pathway, without reducing the chemotherapy's anticancer efficacy. These findings highlight a promising avenue for managing chemotherapy-induced neuropathy without compromising cancer treatment outcomes.

• Flubendazole in Precision Autophagy Research: Mechanisms and

  2026-05-23

  Explore the advanced roles of Flubendazole as a benzimidazole autophagy activator in cancer and cellular signaling research. This article offers unique, protocol-focused insights and critical analysis of recent mechanistic findings for optimizing experimental design.

• HyperFluor™ 594 Goat Anti-Rabbit IgG: Precision in Tumor Nan

  2026-05-22

  Explore how the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody empowers high-sensitivity imaging and quantification in advanced tumor nanocarrier studies. This article uniquely bridges fluorescence-based detection with innovations in biomimetic drug delivery, offering practical guidance for next-generation research.

• YAP-TEAD Pathway Mediates PPARα-Induced Hepatomegaly in Mice

  2026-05-22

  This study establishes that PPARα activation by WY-14643 (Pirinixic Acid) induces hepatomegaly and liver regeneration in mice via the YAP-TEAD transcriptional pathway. The findings clarify a critical mechanistic link between nuclear receptor signaling and liver growth, with implications for metabolic disorder research and regenerative therapeutics.

• Platanoside Prevents Ferroptosis in Acute Lung Injury via Ke

  2026-05-21

  The referenced study demonstrates that platanoside, a natural flavonoid glycoside, prevents ferroptosis in acute lung injury by promoting autophagic degradation of Keap1, thus activating the Nrf2/GPX4 antioxidant axis. These findings reveal a novel therapeutic mechanism for targeting oxidative stress and ferroptosis in pulmonary pathologies.

• In Vitro Drug Response Metrics: Insights for Cancer Epigenet

  2026-05-21

  Schwartz’s dissertation advances the evaluation of anti-cancer drug responses by distinguishing between growth inhibition and cell death in vitro. This nuanced approach informs more precise assessments of epigenetic modulators like DNA methyltransferase inhibitors, with direct implications for experimental design in cancer research.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-05-20

  This study introduces a gastric cancer assembloid model integrating autologous tumor organoids and stromal cell subpopulations, more accurately reflecting the native tumor microenvironment. The platform enables nuanced drug response assessment and investigation of resistance mechanisms, advancing the field of personalized preclinical oncology research.

• Bifendate Suppresses Autophagy and Lipid Accumulation Mechan

  2026-05-20

  Yuan et al. (2022) elucidate how bifendate (DDB) impairs multiple stages of autophagy, notably inhibiting autophagosome-lysosome fusion and lysosomal acidification, thereby reducing oleic acid-induced intracellular lipid droplet buildup. These findings clarify a mechanistic link between bifendate's autophagy modulation and hepatic lipid metabolism, offering new angles for metabolic liver disease research.

• Gepotidacin: Mechanistic Insights & Assay Impact in Antibact

  2026-05-19

  Discover the molecular mechanism of Gepotidacin (GSK2140944) and its transformative role in antibacterial research. This article provides an in-depth analysis of practical assay design, integrating advanced scientific insight and comparative context beyond prior reviews.

• QPRT-P2Y11 Axis Drives Breast Cancer Invasion via MLC Phosph

  2026-05-19

  Liu et al. (2021) elucidate a mechanistic link between upregulated QPRT expression and enhanced invasiveness of breast cancer cells, implicating myosin light chain (MLC) phosphorylation via purinergic P2Y11 receptor signaling. Pharmacological inhibition of P2Y11 reverses this invasive phenotype, providing new insight into cancer cell migration and potential research avenues for metastasis intervention.

• Merbromin as a Mixed-Type Inhibitor of SARS-CoV-2 3CLpro Pro

  2026-05-18

  This study identifies Merbromin as a selective, mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro) using high-throughput enzymatic screening of ~6,000 compounds. The findings clarify Merbromin's mechanism of inhibition and provide a structural basis for developing future antiviral agents.

15973 records 1/1065 page Next 12345 下5页 Last page